All Articles

A record share of Americans are relocating, fleeing high costs for the Sun Belt. This isn't just about sunshine; it's a strategic economic shift.

AMR Clinical's acquisition of ClinOhio isn't just about growth; it's a strategic move in a booming market, promising faster drug development for sponsors.

A new audio series, 'Nature, Inc.', rejects TikTok-style snippets for deep, uncut stories. Is this the media rebellion we've been waiting for?

In a landmark move, Strategy Inc. unveils a new capital framework, trading pure conviction for controlled financial engineering. Is this the blueprint for the future?

A small company claims it can turn municipal waste into green fuel at a disruptive price. With a major research firm's cautious nod, all eyes are on a small Portuguese port.

Landmark Credit Union's five-branch Madison expansion is more than a growth play; it's a strategic fusion of physical presence and deep community investment.

SandboxAQ is bringing its 'Large Quantitative Models' to Google Cloud, promising to slash R&D timelines by blending advanced AI with fundamental physics.

A tech certification may not sound like front-page news, but it signals a crucial step in healing the fragmented digital backbone of American healthcare.

With the launch of Cloud Aurora, Ariana Grande isn't just dropping a new perfume. She's reinforcing a masterclass in building a permanent, resilient brand.

Ottawa is set to announce major funding for space tech, ensuring its critical satellite data feed remains unbroken. What does this mean for national security and the economy?

In one year, Abacus leaped from #20 to #3 on a key industry ranking. An inside look at the strategy of mergers and specialization that's redefining IT for finance and healthcare.

4DMT secures a complex $200M credit facility, choosing strategic debt over equity. We dissect the deal and what it signals for late-stage biotech financing.

The partnership aims to dominate the government AI sector by deploying advanced models for national security, raising both strategic opportunities and ethical questions.

A new blood test and a powerful partnership between a diagnostics firm and a patient foundation aim to end years of misdiagnosis for a rare lung disease.

Intercontinental Exchange is launching futures on central bank decisions and energy data, a bold move to financialize economic news itself.

A Chinese court cleared Biocytogen’s core antibody platform, a ruling that is less about one patent and more about validating a new era of sovereign innovation.

A new patent for a non-hallucinogenic compound positions Clearmind Medicine to disrupt the multi-billion dollar market for addiction and compulsive disorders.

As National Safety Month concludes, experts argue that a people-first culture, not just compliance, is the key to reducing risk and unlocking real business value.

High-grade gold assays at La Flora are not just a win for Latin Metals, but a powerful validation of a de-risked exploration model reshaping junior mining.